000110613 001__ 110613
000110613 005__ 20230519145619.0
000110613 0247_ $$2doi$$a10.31083/j.ejgo4205154
000110613 0248_ $$2sideral$$a127557
000110613 037__ $$aART-2021-127557
000110613 041__ $$aeng
000110613 100__ $$aRuiz Peña A.C.
000110613 245__ $$aHealth related quality of life scales in women diagnosed with gynecological and breast cancer: The role of resilience. A systematic review
000110613 260__ $$c2021
000110613 5060_ $$aAccess copy available to the general public$$fUnrestricted
000110613 5203_ $$aObjective: Resilience and health-related quality of life are factors to be valued today in all types of patients for their relationship to well-being and health. Any stressful situation can significantly impact quality of life and resilience and there are numerous scales to rate these aspects. The main objective of this review is to describe the most used health-related quality of life and resilience scales in gynecological and breast cancer patients to highlight the limitations. Data sources: A review of literature in Pubmed, MEDLINE, Cochrane Database and Google Scholar was carried out to identify articles on health-related quality of life in oncological patients published in English between 2000 and 2020. Methods of study selection: The review was done following the PRISMA guidelines. Tabulation: A total of 460 papers were identified using MeSH terms but finally, according to the inclusion and exclusion criteria, we evaluated 41. Integration and results: Questionnaires have a good performance to quantify quality of life and resilience in oncological patients in general. However, most publications were not focused on patients with gynecological cancer. Conclusions: Due to the particularities of the group of patients with gynecologic and breast cancer secondary to their treatment significantly affecting several areas and domains, it is necessary to validate specific scales for them in order to offer these patients the correct management of their disease at all levels. The role of resilience, premature and iatrogenic menopause and mutilating surgeries are essential to understand the uniqueness of health-related quality of life in gynecological and breast cancer patients. ©2021 The Author(s).
000110613 540__ $$9info:eu-repo/semantics/openAccess$$aby$$uhttp://creativecommons.org/licenses/by/3.0/es/
000110613 590__ $$a0.255$$b2021
000110613 592__ $$a0.0$$b2021
000110613 591__ $$aONCOLOGY$$b243 / 245 = 0.992$$c2021$$dQ4$$eT3
000110613 593__ $$aOncology$$c2021
000110613 591__ $$aOBSTETRICS & GYNECOLOGY$$b83 / 85 = 0.976$$c2021$$dQ4$$eT3
000110613 593__ $$aObstetrics and Gynecology$$c2021
000110613 655_4 $$ainfo:eu-repo/semantics/article$$vinfo:eu-repo/semantics/publishedVersion
000110613 700__ $$aGutiérrez Y.J.
000110613 700__ $$aSierra J.N.
000110613 700__ $$aEspiau Romera, A.$$uUniversidad de Zaragoza
000110613 700__ $$aMartín P.C.
000110613 700__ $$aBaquedano Mainar, L.$$uUniversidad de Zaragoza
000110613 7102_ $$11013$$2645$$aUniversidad de Zaragoza$$bDpto. Cirugía$$cÁrea Obstetricia y Ginecología
000110613 773__ $$g42, 5 (2021), 1048-1057$$pEur. j. gynaecol. oncol.$$tEUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY$$x0392-2936
000110613 8564_ $$s1785322$$uhttps://zaguan.unizar.es/record/110613/files/texto_completo.pdf$$yVersión publicada
000110613 8564_ $$s2923521$$uhttps://zaguan.unizar.es/record/110613/files/texto_completo.jpg?subformat=icon$$xicon$$yVersión publicada
000110613 909CO $$ooai:zaguan.unizar.es:110613$$particulos$$pdriver
000110613 951__ $$a2023-05-18-16:14:12
000110613 980__ $$aARTICLE